Epidemiology and treatment approaches in management of invasive fungal infections
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2011/05/01
-
Journal
-
Indian UGC (journal)
-
Citations3
-
James Ito
-
Kriengkauykiat
-
Sanjeet Dadwal
-
Kriengkauykiat
Cite
Ito, James, and Sanjeet Dadwal. “Epidemiology and Treatment Approaches in Management of Invasive Fungal Infections”. Clinical Epidemiology, 2011, p. 175, https://doi.org/10.2147/clep.s12502.
Ito, J., & Dadwal, S. (2011). Epidemiology and treatment approaches in management of invasive fungal infections. Clinical Epidemiology, 175. https://doi.org/10.2147/clep.s12502
Ito J, Dadwal S. Epidemiology and treatment approaches in management of invasive fungal infections. Clinical Epidemiology. 2011;:175.
Journal Categories
Medicine
Internal medicine
Infectious and parasitic diseases
Medicine
Internal medicine
Special situations and conditions
Industrial medicine
Industrial hygiene
Medicine
Medicine (General)
Medicine
Public aspects of medicine
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Discovery of BRD4–HDAC Dual Inhibitors with Improved Fungal Selectivity and Potent Synergistic Antifungal Activity against Fluconazole-Resistant Candida albicans | Journal of Medicinal Chemistry |
| 7 | 2023 |
Anti-Fungal Efficacy and Mechanisms of Flavonoids | Antibiotics |
| 157 | 2020 |
Antimicrobial Activity Evaluation on Silver Doped Hydroxyapatite/Polydimethylsiloxane Composite Layer | BioMed Research International |
| 31 | 2015 |
Citations Analysis
The category
Medicine: Therapeutics. Pharmacology 2
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Antimicrobial Activity Evaluation on Silver Doped Hydroxyapatite/Polydimethylsiloxane Composite Layer and was published in 2015. The most recent citation comes from a 2023 study titled Discovery of BRD4–HDAC Dual Inhibitors with Improved Fungal Selectivity and Potent Synergistic Antifungal Activity against Fluconazole-Resistant Candida albicans. This article reached its peak citation in 2023, with 1 citations. It has been cited in 3 different journals, 33% of which are open access. Among related journals, the Journal of Medicinal Chemistry cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.